On the heels of yesterday's double-digit gains, Vanda Pharmaceuticals (VNDA) announces the...

|About: Vanda Pharmaceuticals Inc. (VNDA)|By:, SA News Editor

On the heels of yesterday's double-digit gains, Vanda Pharmaceuticals (VNDA) announces the submission of an NDA for Tasimelteon, which the company hopes can become the first FDA approved treatment for Non-24 hour disease in the totally blind. (PR)